Igor Matushansky

Igor Matushansky currently works at Crescendo Biologics Ltd., as Non-Executive Director from 2018, The Trustees of Columbia University in The City of New York, as Assistant Professor, and Immuneering Corp., as Chief Medical Officer from 2025.
Dr. Matushansky also formerly worked at Ipsen SA, as Senior VP & Head-Oncology Development from 2022 to 2023, Daiichi Sankyo, Inc., as Global Head-Oncology Early Development from 2015 to 2017, HOOKIPA Pharma, Inc., as Chief Medical Officer & Global Head-Research from 2017 to 2022, Sail Biomedicines Inc, as Chief Medical Officer from 2023 to 2025, and Columbia University Irving Medical Center, as Professor from 2007 to 2012.
Dr. Matushansky received his undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate degree from Albert Einstein College of Medicine, Inc.